Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Matthew Peppercorn, M.D.

Concepts (404)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medical Oncology33202322153.580 Why?
Breast Neoplasms812023206153.150 Why?
Neoplasms592023214102.460 Why?
Informed Consent1020229861.760 Why?
Cytochrome P-450 CYP2D6820161081.670 Why?
Tamoxifen1020169811.200 Why?
Quality of Life302023125091.100 Why?
Early Detection of Cancer6202230211.090 Why?
Exercise Therapy1020238911.030 Why?
Health Care Costs11202331950.980 Why?
Biological Specimen Banks220196910.970 Why?
Clinical Trials as Topic14201978710.880 Why?
Ethics Consultation12022460.850 Why?
Antineoplastic Agents, Hormonal13202215000.830 Why?
Sleep Initiation and Maintenance Disorders220209870.800 Why?
Music120232510.750 Why?
Medical Assistance220171020.720 Why?
Biopsy11202267570.690 Why?
Therapies, Investigational220101130.660 Why?
Tissue Banks120191860.650 Why?
Health Expenditures8202123510.650 Why?
Cost of Illness8202318430.640 Why?
Mastectomy, Segmental620209570.630 Why?
Mass Screening5202252200.630 Why?
Health Care Rationing320214380.620 Why?
Chemotherapy, Adjuvant18202334570.610 Why?
Patients620218810.600 Why?
Humans16820237369400.580 Why?
Cost-Benefit Analysis10202253590.560 Why?
Health Services Needs and Demand3202014130.540 Why?
Exercise7202155700.540 Why?
Drug Costs4201911030.530 Why?
Health Knowledge, Attitudes, Practice8201639000.510 Why?
Fear3202114180.510 Why?
Survivors12202322610.490 Why?
Patient Preference220198820.490 Why?
Nurse Practitioners120172660.480 Why?
Insurance, Health3201724920.480 Why?
Female10420233785100.480 Why?
Antineoplastic Agents102021136380.460 Why?
Physicians, Primary Care120195730.440 Why?
Pharmacogenetics220146830.430 Why?
Selective Estrogen Receptor Modulators220091280.430 Why?
Biomedical Research7202033010.420 Why?
Continuity of Patient Care1201910530.410 Why?
Tissue Extracts120121360.410 Why?
Physician-Patient Relations7202132060.410 Why?
Practice Guidelines as Topic8201972750.410 Why?
Emotions2202326210.410 Why?
Attitude of Health Personnel7201938440.400 Why?
Ethics, Medical320227950.400 Why?
Neoplasm Recurrence, Local10202291290.400 Why?
Genetic Research120121730.390 Why?
Public Opinion120154690.390 Why?
Patient Participation6201914360.380 Why?
Clinical Trials, Phase II as Topic120136190.380 Why?
Mandatory Testing12010230.370 Why?
Fertility620227720.370 Why?
Private Sector120133920.370 Why?
Learning1201916820.360 Why?
Drug Industry320177440.360 Why?
Databases as Topic120124760.360 Why?
Decision Making6201838450.360 Why?
Perception2201511750.350 Why?
Carcinoma2202123830.350 Why?
Health Behavior2201926130.340 Why?
Off-Label Use120101690.340 Why?
Receptor, erbB-28202323650.340 Why?
Health Services Accessibility7202051150.330 Why?
Mammography2201724520.330 Why?
Randomized Controlled Trials as Topic7202197570.330 Why?
Comparative Effectiveness Research120146810.330 Why?
Middle Aged5720232131150.330 Why?
Health Resources120149100.320 Why?
Urologic Neoplasms120123100.320 Why?
Adult5620232132830.320 Why?
Neoadjuvant Therapy6202026520.310 Why?
Delivery of Health Care, Integrated220129490.290 Why?
Cross-Sectional Studies132021245980.290 Why?
Estrogen Receptor alpha220215790.280 Why?
Aged4420231626790.280 Why?
Receptors, Estrogen5202021690.280 Why?
Self Efficacy320156110.280 Why?
Patient Acceptance of Health Care3201829950.270 Why?
Quality of Health Care6201843690.270 Why?
Epidemiologic Research Design120093700.270 Why?
Clinical Trials, Phase III as Topic120098100.260 Why?
Attitude220207700.260 Why?
Oxygen Consumption5202318890.250 Why?
Adaptation, Psychological7202225530.240 Why?
Information Dissemination1201211030.230 Why?
Medical Errors1201212920.230 Why?
Patient-Centered Care2202214320.230 Why?
Cost Sharing220174070.230 Why?
Patient Selection4201442220.230 Why?
Societies, Medical7201937410.220 Why?
Pilot Projects5202382590.220 Why?
Research Support as Topic120077050.220 Why?
Polymorphism, Genetic1201343380.220 Why?
Employment1200911130.220 Why?
Socioeconomic Factors9202177150.210 Why?
Physicians5201645200.210 Why?
Body Composition1201124060.200 Why?
Mastectomy5202117700.200 Why?
Life Style3202138080.200 Why?
Receptors, Progesterone3202110960.200 Why?
Prospective Studies202023528060.200 Why?
Ethics Committees, Research120221940.190 Why?
Income4202118610.190 Why?
Genotype92020129630.190 Why?
BRCA2 Protein220227930.180 Why?
Telemedicine3202228020.180 Why?
Anxiety3202342170.180 Why?
Data Collection4201433470.180 Why?
Combined Modality Therapy8202286010.180 Why?
United States212023693620.180 Why?
Antineoplastic Combined Chemotherapy Protocols62020113950.180 Why?
Publishing120078260.180 Why?
Habits120201360.170 Why?
Neoplasm Staging102022109680.170 Why?
Aged, 80 and over222021577380.170 Why?
Feasibility Studies4202350500.170 Why?
Genomics4202356820.170 Why?
Resource Allocation120213450.170 Why?
Medication Adherence6202220410.160 Why?
Health Status Disparities2201217690.160 Why?
Pregnancy Complications, Neoplastic120202530.160 Why?
Carcinoma, Ductal, Breast3202011060.160 Why?
BRCA1 Protein2202211410.160 Why?
Receptor, Fibroblast Growth Factor, Type 1120192500.160 Why?
Menopause4201716100.160 Why?
Hypertension, Pregnancy-Induced120234750.160 Why?
Healthcare Disparities5201731210.150 Why?
Nontherapeutic Human Experimentation12017230.150 Why?
Medicare2201564400.150 Why?
Radiotherapy, Adjuvant3202117640.150 Why?
Palliative Care3202034400.150 Why?
Bone Marrow Transplantation1200527620.150 Why?
Clinical Trials, Phase I as Topic220223150.150 Why?
Organizational Policy120194270.150 Why?
Male2620213490250.150 Why?
Aromatase Inhibitors320154900.140 Why?
Patient Satisfaction4202133670.140 Why?
Fatigue2202215120.140 Why?
National Cancer Institute (U.S.)120172810.140 Why?
Treatment Outcome142021625010.140 Why?
Communication5201936570.140 Why?
Antimetabolites, Antineoplastic120206410.140 Why?
Carcinoma, Ductal120161040.140 Why?
Health Planning120172370.140 Why?
Diphosphonates220126260.140 Why?
Financial Support220131150.140 Why?
Rural Population2201721810.140 Why?
Fasting1202215940.140 Why?
Prognosis82020289670.130 Why?
Delivery of Health Care4201952370.130 Why?
Breast2202219260.130 Why?
Resilience, Psychological120226500.130 Why?
Gene Expression Profiling3201994210.130 Why?
Focus Groups1201912970.120 Why?
Health Priorities120173820.120 Why?
Social Support2202221020.120 Why?
Stress, Psychological3202242060.120 Why?
Patient Education as Topic2201422790.120 Why?
Age Factors72021183590.120 Why?
Organizational Affiliation12013320.120 Why?
Needs Assessment1202011430.120 Why?
Reaction Time1201921010.110 Why?
Evidence-Based Practice120175000.110 Why?
Young Adult122022562390.110 Why?
Ethics Committees12012540.110 Why?
Exercise Test3201420740.110 Why?
Health Care Surveys2201824510.100 Why?
Aftercare120188450.100 Why?
Polymorphism, Single Nucleotide22020155050.100 Why?
North Carolina120123080.100 Why?
Medically Uninsured120178510.100 Why?
Disease Management2202024540.100 Why?
Cost Savings220149230.100 Why?
Evidence-Based Medicine3201636130.100 Why?
Angiogenesis Inducing Agents120132830.100 Why?
Cardiovascular Physiological Phenomena120132370.100 Why?
Culture120156240.100 Why?
Skinfold Thickness120111620.100 Why?
Tissue Donors1202022310.100 Why?
Plethysmography120111790.100 Why?
Cluster Analysis1201827550.100 Why?
Ambulatory Care1202127160.090 Why?
Research2201020100.090 Why?
Disclosure220147350.090 Why?
Choice Behavior120167980.090 Why?
Awareness120146370.090 Why?
TOR Serine-Threonine Kinases1201921200.090 Why?
Family1202131200.090 Why?
Biotransformation120091650.090 Why?
Immunization1201412500.090 Why?
Mind-Body Therapies220232470.090 Why?
Patient Advocacy120123540.090 Why?
Marital Therapy12009450.090 Why?
Hematologic Neoplasms1202117990.090 Why?
Educational Status1201724910.080 Why?
Carcinoma, Lobular120134830.080 Why?
Multivariate Analysis32019122450.080 Why?
Research Design3202259650.080 Why?
Cyclophosphamide3201322290.080 Why?
Live Birth220235130.080 Why?
Germ Cells220226330.080 Why?
National Institutes of Health (U.S.)120127780.080 Why?
Models, Economic220117110.080 Why?
Complementary Therapies120124840.080 Why?
Conflict of Interest120135400.080 Why?
Patient Protection and Affordable Care Act1201812050.080 Why?
Risk Assessment82018232980.080 Why?
Radiation Oncology120145480.080 Why?
Retrospective Studies72023762000.080 Why?
Costs and Cost Analysis3201816730.080 Why?
Electric Impedance120117160.070 Why?
Adjuvants, Immunologic220229860.070 Why?
Human Experimentation120071270.070 Why?
Endpoint Determination120106020.070 Why?
Caregivers1201820410.070 Why?
Quality Indicators, Health Care1201718360.070 Why?
Logistic Models42017134080.070 Why?
Vaccination2201832110.070 Why?
Imidazoles1201212220.070 Why?
Decision Support Techniques1201619560.070 Why?
Communicable Diseases120148630.070 Why?
Carmustine120051370.070 Why?
Secondary Prevention1201215090.070 Why?
Drug Evaluation120076390.070 Why?
Patient Care Team2201625290.070 Why?
Drug Approval120127400.070 Why?
Mental Health1201929010.070 Why?
Follow-Up Studies52020389370.070 Why?
Health Surveys1201540170.070 Why?
Health Personnel1201831800.060 Why?
Survival Analysis22008102610.060 Why?
Premenopause1200910260.060 Why?
Guideline Adherence2201222610.060 Why?
Consensus1201428850.060 Why?
Anti-Bacterial Agents1202370880.060 Why?
Drug Administration Schedule2201149350.060 Why?
Ovary120099810.060 Why?
Mutation42023298440.060 Why?
Cancer Vaccines1201210200.060 Why?
Survival Rate42016127820.060 Why?
Authorship120072660.060 Why?
Alleles1201569450.060 Why?
Cohort Studies52023402930.060 Why?
United States Food and Drug Administration1201215850.060 Why?
Leukemia1201215010.060 Why?
Multiple Myeloma1202151220.060 Why?
Oligonucleotide Array Sequence Analysis2201339360.060 Why?
Walking1201011700.060 Why?
Protein Kinase Inhibitors1201954990.060 Why?
Phenotype32020163750.050 Why?
Probability1200824960.050 Why?
Ontario120233740.050 Why?
Patient Care120076350.050 Why?
Pregnancy Outcome2202327870.050 Why?
Postmenopause1201024510.050 Why?
Adolescent72022852250.050 Why?
Neoplasm Metastasis3201948530.050 Why?
Time Factors42020401310.050 Why?
Fluoroquinolones120233020.050 Why?
Ferredoxin-NADP Reductase12020130.050 Why?
Transplantation, Autologous1200521140.050 Why?
Reference Values1200849910.050 Why?
Advisory Committees220167710.050 Why?
Administration, Oral1200839060.050 Why?
Risk Factors62021717840.040 Why?
Cisplatin1200516130.040 Why?
Pharmacies120211480.040 Why?
Heart Failure12023107030.040 Why?
Reproducibility of Results22022197770.040 Why?
Bipolar Disorder1201650040.040 Why?
Oxygen1201041740.040 Why?
Methylenetetrahydrofolate Reductase (NADPH2)120202850.040 Why?
Blood Donors120203610.040 Why?
Academies and Institutes120203150.040 Why?
Patient Compliance2202126840.040 Why?
Cancer Care Facilities120204000.040 Why?
Class I Phosphatidylinositol 3-Kinases120228980.040 Why?
Health Promotion1201021740.040 Why?
Lung1201697960.040 Why?
Pregnancy42023288500.040 Why?
Pregnancy Rate120206440.040 Why?
Prescription Fees120181470.040 Why?
Insurance Coverage2201818890.040 Why?
Doxorubicin2201322150.040 Why?
Anthracyclines120182830.040 Why?
Immunotherapy1201243500.040 Why?
Genetic Testing1200934750.030 Why?
Heterozygote1202228170.030 Why?
Body Image120205970.030 Why?
Adenocarcinoma1201363810.030 Why?
Attitude to Health1200420490.030 Why?
Proportional Hazards Models12009123370.030 Why?
Confidence Intervals1202029760.030 Why?
Gene Amplification1201910720.030 Why?
Gene Expression1200878160.030 Why?
Age Distribution1202029040.030 Why?
Antibiotics, Antineoplastic120186910.030 Why?
Adjuvants, Pharmaceutic12014490.030 Why?
Case-Control Studies22013216950.030 Why?
Psychotherapy1202316200.030 Why?
Odds Ratio2202098600.030 Why?
Chromosomes, Human, Pair 21119932300.030 Why?
Immunocompromised Host120188450.030 Why?
Genital Neoplasms, Female120185140.030 Why?
Dose-Response Relationship, Drug12005109580.030 Why?
Genome-Wide Association Study12012121460.030 Why?
Chromosomes, Human, Pair 14119933030.030 Why?
Genes, BRCA2120166170.030 Why?
Tissue and Organ Procurement120208970.030 Why?
Depression2202376450.030 Why?
Placebos1201716790.030 Why?
Virus Diseases120187080.030 Why?
Genes, BRCA1120167790.030 Why?
Germ-Line Mutation1202018010.030 Why?
Weight Gain1202222770.030 Why?
Lymphatic Metastasis1201929080.030 Why?
Analysis of Variance1202063770.030 Why?
Mammaplasty1202111690.030 Why?
Lymphedema120185340.030 Why?
Models, Theoretical1200436020.030 Why?
Body Weight1202246660.020 Why?
Behavior120145610.020 Why?
Cost Control120136280.020 Why?
Terminology as Topic1201815550.020 Why?
Health Policy2201126590.020 Why?
Tumor Burden1201719070.020 Why?
Weight Loss1202225950.020 Why?
Comprehension120166050.020 Why?
Algorithms12011138690.020 Why?
Postoperative Care1201714800.020 Why?
Radiotherapy Dosage1201728750.020 Why?
Cognition1200766190.020 Why?
Immunoenzyme Techniques1201318050.020 Why?
Bacterial Infections1201813930.020 Why?
Incidence12008208830.020 Why?
Longitudinal Studies22018138370.020 Why?
Personal Satisfaction120146220.020 Why?
Predictive Value of Tests22016150790.020 Why?
Health Services Misuse120112440.020 Why?
Piperazines1201924740.020 Why?
Tumor Suppressor Protein p531201929650.020 Why?
Genes1199318980.020 Why?
Sick Role120092380.020 Why?
Developing Countries1202127620.020 Why?
Safety1201311900.020 Why?
Forecasting1201729470.020 Why?
Physical Fitness120137320.020 Why?
Australia1201111630.020 Why?
Lymph Nodes1201934650.020 Why?
Exercise Tolerance120137670.020 Why?
Standard of Care120125620.020 Why?
Beneficence12007530.020 Why?
Massachusetts1202186690.020 Why?
Boston1202192980.020 Why?
Guidelines as Topic1201414060.020 Why?
Child32022767000.020 Why?
Pyridines1201928090.020 Why?
Pain1202248870.020 Why?
Cardiovascular Diseases12013149680.020 Why?
Amyloid beta-Protein Precursor1199311240.020 Why?
Cardiovascular System120148230.020 Why?
Ventricular Function, Left1201836020.020 Why?
Genetic Association Studies1201527010.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201347690.020 Why?
Stroke Volume1201849080.020 Why?
Genetic Predisposition to Disease22022174190.020 Why?
Europe1201133150.020 Why?
Drug Resistance, Neoplasm1201951520.020 Why?
Inflammation Mediators1201318880.010 Why?
Referral and Consultation1201634950.010 Why?
Health Services Research1201118370.010 Why?
Education, Medical1199517080.010 Why?
Depressive Disorder1201637410.010 Why?
Infant, Newborn12023254280.010 Why?
Neovascularization, Pathologic1201326440.010 Why?
Curriculum1199535480.010 Why?
Goals120076910.010 Why?
Alzheimer Disease2199379000.010 Why?
Health Care Reform1201112600.010 Why?
Oxidative Stress1201330980.010 Why?
Attention Deficit Disorder with Hyperactivity1201635820.010 Why?
Diagnosis, Differential12016129940.010 Why?
Electrocardiography1201464240.010 Why?
Endothelium, Vascular1201344890.010 Why?
Stem Cells1201335690.010 Why?
Motivation1200919610.010 Why?
RNA, Messenger12013130560.010 Why?
Carcinoma, Non-Small-Cell Lung1201651530.010 Why?
Hospitalization12016101560.010 Why?
Diet1201478940.010 Why?
Risk1200497040.010 Why?
Lung Neoplasms12016129920.010 Why?
Chromosomes, Human119934580.010 Why?
Genetic Linkage1199324370.000 Why?
Genetic Markers1199326390.000 Why?
Pedigree1199346590.000 Why?
Chromosome Mapping1199347390.000 Why?
Models, Biological1199396150.000 Why?
Peppercorn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (404)
Explore
_
Co-Authors (110)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.